- Market size
- Nutraceuticals demand in Europe is a mid-sized but well-defined addressable market for fermentation-derived ingredients, concentrated in a small number of large buyers.
- Growth
- Volumes are growing steadily, pulled by reformulation towards non-animal and non-GMO protein inputs.
- Regulatory
- Standard novel-food authorisation applies before commercial supply.
- NOVAKERN fit
- NOVAKERN's carrier-protein line maps onto this cell with some additional downstream work; margin is tight against current cost of goods.
- Competition
- Contested by established ingredient houses plus two or three fermentation entrants; genuine differentiation sits in purity spec and supply reliability rather than novelty.
Comments
No comments yet. Use @name to mention a teammate.